David Thomson
2013 - MannKind
In 2013, David Thomson earned a total compensation of $4.4M as Corporate Vice President, General Counsel and Secretary at MannKind, a 309% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $197,597 |
|---|---|
| Option Awards | $1,608,300 |
| Salary | $387,440 |
| Stock Awards | $2,204,510 |
| Other | $30,941 |
| Total | $4,428,788 |
Thomson received $2.2M in stock awards, accounting for 50% of the total pay in 2013.
Thomson also received $197.6K in non-equity incentive plan, $1.6M in option awards, $387.4K in salary and $30.9K in other compensation.
Rankings
In 2013, David Thomson's compensation ranked 1,502nd out of 12,286 executives tracked by ExecPay. In other words, Thomson earned more than 87.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,502 out of 12,286 | 88th |
Division Manufacturing | 489 out of 4,612 | 89th |
Major group Chemicals And Allied Products | 130 out of 1,462 | 91st |
Industry group Drugs | 88 out of 1,156 | 92nd |
Industry Pharmaceutical Preparations | 78 out of 890 | 91st |
Source: SEC filing on April 21, 2016.
Thomson's colleagues
We found four more compensation records of executives who worked with David Thomson at MannKind in 2013.
News
PRECISION BIOSCIENCES CEO Matthew Kane's 2020 pay slips 15% to $1.8M
April 12, 2021
MannKind CEO Michael PharmD's 2019 pay rises 3% to $1.6M
April 10, 2020
PRECISION BIOSCIENCES Chief Medical Officer Christopher Heery receives $2.2M in 2019
March 27, 2020
MannKind CEO Michael Castagna's 2018 pay rises 13% to $1.5M
March 28, 2019